Roche Completing Foundation Medicine Buyout In $2.4 Billion Transaction
June 20, 2018
Swiss multinational healthcare company Roche Holdings has entered a definitive merger agreement with Foundation Medicine in a transaction that values the Cambridge, Massachusetts, company at $5.3 billion. Roche already owns a majority stake in Foundation, and the deal to acquire the remainder of the latter’s outstanding common stock would complete the merger between the two companies.